Giving two monoclonal antibodies along with antibiotics cut recurrence of Clostridium difficile (c. diff) infection significantly.
When a single injection of the two antibodies against c. difficile toxins was given, 7 percent of patients had their infection return within the next 84 days. In comparison, patients who got a placebo shot, had a 25 percent recurrence rate.
The antibodies were even more effective in preventing recurrence in patients who had had more than one episode of c. diff. Read the rest of this entry »